US FDA invites biologics sponsors to participate in electronic submission pilot
This article was originally published in SRA
The US Food and Drug Administration is inviting biologic drug makers to participate in a pilot programme to test the value of using its new electronic data standard format to submit non-clinical study data related to investigational new drug applications1.
You may also be interested in...
Oral explanation meetings are due to take place this week for drug sponsors who have a final chance to address questions and concerns the European Medicines Agency has about their marketing applications.
The EU marketing application for cefiderocol that lost fast track status last July is now up for an opinion by the European Medicines Agency.
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.